selected scholarly activity
-
chapters
- Cancer and thrombosis. 72-87. 2014
- Central Venous Line-related Thrombosis. 91-103. 2012
- Cerebral Sinovenous Thrombosis in Children with Cancer. 83-90. 2012
- Thromboembolism in Children with Cancer. 71-81. 2012
-
conferences
- Prognostic factors and outcomes of infant acute lymphoblastic leukemia (ALL), hypodiploid ALL, and mixed-phenotype acute leukemia (MPAL) in Canada: a report from CYP-C.. Leukemia and Lymphoma. 3208-3216. 2022
- Bone health in long-term survivors of pediatric acute lymphoblastic leukemia. An assessment by peripheral quantitative computed tomography. Pediatric Blood and Cancer. 2021
- Impact of Age, Body Surface Area, and Body Mass Index on Pegaspargase Toxicity and Pharmacokinetics: A Report from the DFCI ALL Consortium. Blood. 3396-3396. 2021
- OUTCOMES PREDICTORS OF INFANT ALL, HYPODIPLOID ALL AND MPAL IN CANADA: A POPULATION-BASED STUDY. Pediatric Blood and Cancer. S51-S51. 2021
- PEDIATRIC AND ADULT JOINT HEMOGLOBINOPATHY CLINIC: AN EXPERIENCE OF SEAMLESS TRANSITION OF CARE. Pediatric Blood and Cancer. S88-S89. 2021
- PHASE-SPECIFIC RISKS OF EMERGENCY VISITS AND HOSPITALIZATIONS DURING COG-BASED ALL TREATMENT. Pediatric Blood and Cancer. S50-S50. 2021
- Transfusion-related Iron Overload in Children With Leukemia. Journal of Pediatric Hematology/Oncology. 18-23. 2021
- Emergency Department Quality of Care for Sickle Cell Disease in Ontario, Canada: A Population-Based Matched Cohort Study. Blood. 38-39. 2020
- Frequency and Prognostic Significance of Recurrent Gene Mutations in Pediatric B-ALL: Report from the DFCI ALL Consortium. Blood. 15-16. 2020
- Impact of Thromboembolism on Overall and Event-Free Survival in Children with Acute Lymphoblastic. Blood. 51-52. 2020
- Inter-Relationships of Bone Mineral Density with Fat Mass and Fat-Free Mass in Long Term Survivors of Acute Lymphoblastic Leukemia in Childhood and Adolescence. Pediatric Blood and Cancer. S242-S242. 2019
- Genetic Ancestry and Skeletal Toxicities Among Childhood Acute Lymphoblastic Leukemia Patients in the DFCI 05-001 Cohort. Blood. 3811-3811. 2019
- HIGH VS. LOW-INTENSITY BRIDGING CHEMOTHERAPY WHEN AWAITING CAR-T THERAPY: A POPULATION- BASED STUDY. Pediatric Blood and Cancer. 2019
- PROGNOSTIC DETERMINANTS IN CHILDHOOD T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA: RESULTS OF DFCI 05001. Pediatric Blood and Cancer. 2019
- VITAMIN D DEFICIENCY IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA/LYMPHOMA: RESULTS OF DFCI 11-001. Pediatric Blood and Cancer. 2019
- Efficacy and toxicity of pegaspargase and calaspargase pegol in childhood acute lymphoblastic leukemia/lymphoma: Results of DFCI 11-001.. Journal of Clinical Oncology. 10006-10006. 2019
- Glycemic Control in Patients Treated with Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia: A Systematic Review. Blood. 4273-4273. 2018
- High Vs. Low-Intensity Bridging Chemotherapy in Children with Acute Lymphoblastic Leukemia Awaiting Chimeric Antigen Receptor T-Cell Therapy: A Population-Based Study from Ontario, Canada. Blood. 1410-1410. 2018
- Increasing Incidence and Prevalence of Pathologic Hemoglobinopathies Among Children in Ontario, Canada from 1991-2013. Blood. 4698-4698. 2018
- Challenges in Undertaking a Multi-Center Prospective, Observational, Cohort Study in the Pediatric Oncology Population. Pediatric Blood and Cancer. S497-S498. 2018
- Thrombo-Embolism Incidence and Risk Factors in Children with Cancer: A Population-Based Cohort Study. Pediatric Blood and Cancer. S64-S64. 2018
- CARDIOVASCULAR SIGNALING PROTEINS AS PREDICTORS OF DOXORUBICIN-RELATED CARDIAC EFFECTS IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA. Journal of the American College of Cardiology. A927-A927. 2018
- Age and ABO Blood Group Are Significant Predictors of Thrombosis in Children with Acute Lymphoblastic Leukemia (ALL): Results from Dana-Farber Cancer Institute (DFCI) ALL Consortium Trial 05-001. Blood. 2017
- Dietary Antioxidant Micronutrient Intake and Toxicity during Remission Induction in Children with Acute Lymphoblastic Leukemia (ALL): Results from Dana-Farber Cancer Institute (DFCI) ALL Consortium Trial 05-001. Blood. 2017
- Serum Ferritin Underestimates Liver Iron Concentration in Patients with Homozygous Alpha-0 Thalassemia. Blood. 2017
- Prevalence of Hemoglobinopathies among Ontario Children after the Implementation of Universal Hemoglobinopathy Screening. Pediatric Blood and Cancer. S74-S74. 2017
- Anticoagulation Therapy for Thrombotic Events in Paediatric Cancer Patients with Low Platelet Counts. Blood. 2625-2625. 2016
- Elucidating the Thrombogenic Risk of Non-O Blood Groups in Children with Acute Lymphoblastic Leukemia (ALL): Is Von Willebrand Factor a Culprit ?. Blood. 4990-4990. 2016
- Evaluation of Mortality during Treatement of Acute Myeloid Leukemia in Patients According to Morocco National AML-MA-2011 Protocol in Casablanca. Blood. 2016
- Excellent Outcome of Children with Down Syndrome (DS) and Acute Lymphoblastic Leukemia (ALL) Treated on Dana-Farber Cancer Institute (DFCI) ALL Consortium Protocols 00-001 and 05-001. Blood. 761-761. 2016
- Kinase-Activating Fusions in Pediatric High-Risk B-Lineage Acute Lymphoblastic Leukemia (ALL): a Report from the Dana-Farber Cancer Institute (DFCI) ALL Consortium. Blood. 1729-1729. 2016
- Outcome of Acute Myeloid Leukemia in Children and Young Adults Treated with an Uniform Protocol in Casablanca, Morocco. Blood. 2016
- Outcome of acute Myeloid Leukemia in Adults Patients Treated According to Morocco National AML-MA-2011 Protocol in Casablanca, Morocco. Blood. 5173-5173. 2016
- Randomized Study of Pegasparagase (SS-PEG) and Calaspargase Pegol (SC-PEG) in Pediatric Patients with Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma: Results of DFCI ALL Consortium Protocol 11-001. Blood. 175-175. 2016
- Baseline Clinical and Laboratory Features Predict Risk of Developing Symptomatic Thromboembolism (STE) During Antileukemic Therapy in Children with De Novo Acute Lymphoblastic Leukemia (ALL). Pediatric Blood and Cancer. S27-S27. 2016
- Red Cell Antigen Genotyping Compared to Serological Phenotyping in Sickle Cell Disease Patients in Canada: Potential for Reducing Alloimmunization. Transfusion. 153A-153A. 2016
- Acute Myeloid Leukaemia in Children: Preliminary Results of a National Protocol in Casablanca, Morocco. Blood. 2015
- Effect of Asparaginase and Dexamethasone on FVIIa-at Complex and F1.2 in Children with Acute Lymphoblastic Leukemia: Evidence of Hypercoagulable State. Blood. 3552-3552. 2015
- Favorable Risk Group Acute Myeloid Leukemia in Children and Young Adult Treated in Uniform Protocol in Casablanca, Morocco. a Preliminary Analysis. Blood. 4891-4891. 2015
- Higher Incidence of Treatment-Related Toxicities in Non-Hispanic Patients Undergoing Therapy for Newly Diagnosed Pediatric Acute Lymphoblastic Leukemia on Dana-Farber Cancer Institute ALL Consortium Protocol 05-001. Blood. 2015
- Ikaros Gene Deletion Significantly Predicts Relapse in Pediatric B-ALL Patients with Low End-Induction Minimal Residual Disease. Blood. 2613-2613. 2015
- Red Cell Antigen Genotyping Compared to Standard Serological Phenotyping in Sickle Cell Disease Patients in Canada: Potential for Reducing Alloimmunization. Blood. 2015
- Between a rock and a hard place: conundrums in the management of cerebral sinovenous thrombosis (CSVT) in children with acute lymphoblastic leukemia (ALL)/lymphoma. Journal of Thrombosis and Haemostasis. 551-552. 2015
- Impact of inherited and acquired prothrombotic defects (PD) on the development of symptomatic thromboembolism (STE) in children with acute lymphoblastic leukemia (ALL) treated according to the Dana-Farber Cancer Institute (DFCI) 05-01 All-Therapy Protocol. Journal of Thrombosis and Haemostasis. 428-429. 2015
- Transition of Care Under One Roof at the Mcmaster Hemoglobinopathy Clinic. Blood. 2014
- FEASIBILITY AND SAFETY OF FULL DOSE ANTICOAGULATION THERAPY (ACT) IN CHILDREN TREATED ACCORDING TO DANA-FARBER CANCER INSTITUTE (DFCI) ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) CONSORTIUM THERAPY PROTOCOLS. Pediatric Blood and Cancer. S170-S171. 2014
- IS THERE A ROLE FOR THROMBOPROPHYLAXIS IN PEDIATRIC SARCOMA PATIENTS? A LITERATURE REVIEW FOCUSING ON EPIDEMIOLOGY, RISK FACTORS AND OUTCOMES OF THROMBOEMBOLISM IN SARCOMA PATIENTS. Pediatric Blood and Cancer. S270-S270. 2014
- STANDARD RISK CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) IN MOROCCO: EXPERIENCE OF 170 CASES TREATED IN A SINGLE CENTER. Pediatric Blood and Cancer. S174-S174. 2014
- THE EFFECT OF CRANIAL RADIATION THERAPY (CRT) ON BODY MASS INDEX (BMI) DURING TREATMENT FOR ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) IN CHILDREN: AN EXPLORATORY ANALYSIS. Pediatric Blood and Cancer. S172-S172. 2014
- Development and Validation of a Generic Scale for use in Transition Programs to Measure Self-Management Skills in Adolescents with Chronic Health Conditions: The TRANSITION-Q. Quality of Life Research. 63-63. 2014
- Outcome of childhood T-cell acute lymphoblastic leukemia (T-ALL): Results from DFCI protocol 05-001.. Journal of Clinical Oncology. 10015-10015. 2014
- HEALTH-RELATED QUALITY OF LIFE ASSESSMENT IN CHILDREN AND ADOLESCENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA (ALL): A REPORT FROM DANA-FARBER CANCER INSTITUTE (DFCI) ALL CONSORTIUM PROTOCOL 05-001. Pediatric Blood and Cancer. S85-S85. 2014
- LONG TERM CLINICAL AND NEUROCOGNITIVE OUTOMES OF HOMOZYGOUS ALPHA-THALASSEMIA SURVIVORS. Pediatric Blood and Cancer. S90-S91. 2014
- Results Of The DFCI ALL Consortium Protocol 05-001 For Children and Adolescents With Newly Diagnosed ALL. Blood. 838-838. 2013
- Transfusion Related Alloimmunization In Children: Epidemiology and Effects Of Chemotherapy (TRACE-EC Study). Blood. 1161-1161. 2013
- Transfusion-Related Iron Overload: A Covert Risk Of Supportive Cancer Care. Blood. 3656-3656. 2013
- THE DEVELOPMENT OF THROMBOEMBOLISM MAY INCREASE THE RISK OF OSTEONECROSIS IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA. Pediatric Blood and Cancer. 11-11. 2013
- CEREBRAL SINO-VENOUS THROMBOSIS IN CHILDREN RECEIVING ANTILEUKEMIC THERAPY. Pediatric Blood and Cancer. 972-973. 2012
- CHEMOTHERAPY PASSPORT: A TOOL TO IMPROVE SAFE DELIVERY OF CHEMOTHERAPY. Pediatric Blood and Cancer. 1118-1118. 2012
- Combination of Dexamethasone and Asparaginase Induces Prothrombotic State in Children Receiving Multiagent Chemotherapy for Acute Lymphoblastic Leukemia. Blood. 3536-3536. 2012
- Outcome and Clinical Characteristics of Clonal and Malignant Myeloid Transformation in Inherited Bone Marrow Failure Syndromes. Blood. 1266-1266. 2012
- PCN110 Differences in Health-Related Quality of Life Between Children Treated for Acute Lymphoblastic Leukemia (ALL) on Dana Farber Cancer Institute (DFCI) Protocols. Value in Health. A429-A429. 2012
- Changes in Cardiac Biomarkers During Doxorubicin Treatment of Pediatric Patients With High-Risk Acute Lymphoblastic Leukemia: Associations With Long-Term Echocardiographic Outcomes. Journal of Clinical Oncology. 1042-1049. 2012
- Randomized Comparison of IV PEG and IM E. Coli Asparaginase in Children and Adolescents with Acute Lymphoblastic Leukemia: Results of the DFCI ALL Consortium Protocol 05-01. Blood. 398-399. 2011
- Body mass index and thromboembolism in children with hematological malignancies. Journal of Thrombosis and Haemostasis. 643-643. 2011
- Induction of endothelial von Willebrand's factor expression by precursor B lymphoblasts. Journal of Thrombosis and Haemostasis. 909-909. 2011
- CORTICOSTEROIDS, BEHAVIOUR AND QUALITY OF LIFE IN CHILDREN TREATED FOR ACUTE LYMPHOBLASTIC LEUKEMIA; A MULTI-CENTERED TRIAL. Pediatric Blood and Cancer. 923-924. 2011
- Diagnostic Value of Cardiac Troponin T, N-Terminal Pro-Brain Natriuretic Peptide, and High-Sensitivity C-Reactive Protein During Doxorubicin Therapy in Children with Acute Lymphoblastic Leukemia. Circulation. 2010
- MANAGEMENT OF THROMBOEMBOLISM IN CHILDREN AND ADOLESCENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA. Pediatric Blood and Cancer. 855-856. 2010
- UT3 RELIABILITY OF HEALTH UTILITIES INDEX (HUI) SCORES: PATIENT AND PARENT INTER-RATER AGREEMENT ACROSS TWO CLINICAL TRIALS OF TREATMENT FOR ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) IN CHILDHOOD. Value in Health. A13-A13. 2010
- DECREASED OVERALL SURVIVAL AND INCREASED RISK OF THROMBOSIS IN CHILDREN WITH CANCER AND CENTRAL VENOUS LINE (CVL) DYSFUNCTION. Pediatric Blood and Cancer. 850-850. 2009
- PREDICTORS OF BONY MORBIDITY IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA. Pediatric Blood and Cancer. 721-721. 2009
- REVIEW AND ANALYSIS OF POSITIVE BLOOD CULTURES IN 248 CHILDREN DIAGNOSED WITH CANCER. Pediatric Blood and Cancer. 867-867. 2009
- PREDICTORS OF OSTEOPENIA/OSTEOPOROSIS IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA. Pediatric Blood and Cancer. 716-717. 2009
- COMPARATIVE ANALYSIS OF SHWACHMAN-DIAMOND SYNDROME TO OTHER INHERITED MARROW FAILURE SYNDROMES. Haematologica. S25-S25. 2009
- GENETIC ANALYSIS OF INHERITED BONE MARROW FAILURE SYNDROMES FROM ONE COMPREHENSIVE COHORT OF PATIENTS. Haematologica. S7-S8. 2009
- MALIGNANT MYELOID TRANSFORMATION IN INHERITED BONE MARROW FAILURE SYNDROMES. Haematologica. S25-S25. 2009
- Circulating Blasts Are Associated with High Levels of vWF and Thrombin Activation in Children with Newly Diagnosed ALL. Blood. 642-643. 2008
- Predictors of Osteopenia/Osteoporosis in Children with Acute Lymphoblastic Leukemia. Blood. 336-336. 2008
- Dexrazoxane Cardioprotection In Doxorubicin-Treated Children with Acute Lymphoblastic Leukemia: Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium Protocol 95-01 Randomized Controlled. Circulation. S1055-S1056. 2008
- Isolation and characterization of hemoglobins Portland I, Portland II and Gower I in infants with homozygous alpha(o)-thalassemia. International Journal of Laboratory Hematology. 44-44. 2008
- Peripartum Management of Women with Suspected Hereditary Thrombocytopenia.. Blood. 3224-3224. 2007
- Risk factors predisposing to thromboembolism in children with cancer. Blood. 487A-487A. 2007
- Does mediastinal lymphadenopathy increase the risk of thromboembolism in children with lymphoma?. Pediatric Blood and Cancer. 618-618. 2007
- 78 A case of EBV related PTLD (Post Transplant Lymphoproliferative Disorder) treated successfully with ganciclovir in a patient with Crohn's disease, and review of the literature of PTLD in patients with inflammatory bowel disease. International Journal of Infectious Diseases. S43-S44. 2006
- Thromboembolism in children with sarcoma.. Blood. 108B-108B. 2005
- Intensive therapy for childhood atypical teratoid rhabdold tumor of the central nervous system: A single institution's experience with four cases and a review of the literature. Neuro-Oncology. 449-450. 2004
- Thromboembolism (TE) in children with acute lymphoblastic leukemia (ALL) treated on Dana Farber Cancer Institute (DFCI) protocols: Effect of dose and type (prednisone versus dexamethasone) of steroids used.. Journal of Clinical Oncology. 805S-805S. 2004
- Methemoglobinemia in children with acute lymphoblastic leukemia (ALL) receiving dapsone for Pneumocystis cariniiPneumonia (PCP) prophylaxis: A genetic predisposition. Pediatric Research. 304A-304A. 2004
- Methemoglobinemia in children with acute lymphoblastic leukemia (ALL) receiving dapsone for Pneumocystis carinii pneumonia (PCP) prophylaxis: A genetic predisposition.. Blood. 235B-235B. 2003
- Follow-up of tonsillectomy and adenoidectomy in patients with sickle cell disease.. Journal of Investigative Medicine. 37A-37A. 1998
-
journal articles
- Genome‐wide study identifies novel genes associated with bone toxicities in children with acute lymphoblastic leukaemia. British Journal of Haematology. 205:1889-1898. 2024
- Development and validation of thromboembolism diagnostic algorithms in children with cancer from real-world data. Pediatric Research. 96:695-701. 2024
-
Risk factors and clinical impact of thrombosis during induction chemotherapy for pediatric acute lymphoblastic leukemia: A report from
CYP‐C . American Journal of Hematology. 99:274-283. 2024 - Thromboprophylaxis in paediatric acute lymphoblastic leukaemia. The Lancet Haematology. 11:e3-e5. 2024
- Impairment of health‐related quality of life for children with acute lymphoblastic leukemia over the first year of therapy: A report from the DFCI ALL Consortium. Pediatric Blood and Cancer. 70:e30560. 2023
- Rates and predictors of visits to primary care physicians during and after treatment of childhood acute lymphoblastic leukemia: A population‐based cohort study. Pediatric Blood and Cancer. 70:e30610. 2023
- Safety and Efficacy of Alendronate to Treat Osteopenia in Children During Therapy for Acute Lymphoblastic Leukemia: A Retrospective Cohort Study of Sequential Outcomes. Journal of Pediatric Hematology/Oncology. 45:200-206. 2023
- The Influence of Body Composition on Bone Health in Long-term Survivors of Acute Lymphoblastic Leukemia in Childhood and Adolescence: Analyses by Dual-energy Radiograph Absorptiometry and Peripheral Quantitative Computed Tomography. Journal of Pediatric Hematology/Oncology. 44:423-431. 2022
- Healthcare utilization and costs associated with acute lymphoblastic leukemia in children with and without Down syndrome. Pediatric Blood and Cancer. 69:e29829. 2022
- Predictors of thrombosis in children receiving therapy for acute lymphoblastic leukemia: Results from Dana‐Farber Cancer Institute ALL Consortium trial 05‐001. Pediatric Blood and Cancer. 69:e29581. 2022
- Desmoplastic Small Round Cell Tumor With Ascending Intraspinal Metastasis at Recurrence: Case Report and Review of the Literature. Journal of Pediatric Hematology/Oncology. 44:e561-e566. 2022
- Impact of virtual care on health-related quality of life in children with diabetes mellitus: a systematic review protocol. BMJ Open. 12:e053642-e053642. 2022
- An exploratory analysis of the impact of the COVID-19 pandemic on pediatric type 1 diabetes mellitus patient outcomes: A single-center study. Frontiers in Pediatrics. 10:1038345. 2022
- Bone health in long‐term survivors of pediatric acute lymphoblastic leukemia. An assessment by peripheral quantitative computed tomography. Pediatric Blood and Cancer. 68:e29218. 2021
- Blinatumomab Is Cost-Effective Compared to Standard Chemotherapy for Children with High Risk Relapses of Acute Lymphoblastic Leukemia: A Cost-Effectiveness Analysis Using Population-Based Healthcare Data. Blood. 138:565-565. 2021
- Rates and Predictors of Visits to Primary Care Physicians during and after Treatment of Childhood Acute Lymphoblastic Leukemia: A Population-Based Cohort Study. Blood. 138:839-839. 2021
- Efficacy and Toxicity of Pegaspargase and Calaspargase Pegol in Childhood Acute Lymphoblastic Leukemia: Results of DFCI 11-001. Journal of Clinical Oncology. 39:3496-3505. 2021
- Phase‐specific risks of outpatient visits, emergency visits, and hospitalizations during Children's Oncology Group‐based treatment for childhood acute lymphoblastic leukemia: A population‐based study. Pediatric Blood and Cancer. 68:e29141. 2021
- Impact of ABO Blood Group on the Development of Venous Thromboembolism in Children With Cancer: A Systematic Review and Meta-Analysis. Journal of Pediatric Hematology/Oncology. 43:216-223. 2021
- Health care utilisation and costs associated with different treatment protocols for newly diagnosed childhood acute lymphoblastic leukaemia: A population-based study in Ontario, Canada. European Journal of Cancer. 151:126-135. 2021
-
Thrombosis is associated with worse survival in children with acute lymphoblastic leukemia: A report from
CYP‐C . American Journal of Hematology. 96:796-804. 2021 - Predictors of clinical trial enrollment and impact on outcome in children and adolescents with acute lymphoblastic leukemia: A population based study.. Journal of Clinical Oncology. 39:7031-7031. 2021
- Corrigendum. Pediatric Blood and Cancer. 68:e28885. 2021
- Genetic ancestry and skeletal toxicities among childhood acute lymphoblastic leukemia patients in the DFCI 05-001 cohort. Blood Advances. 5:451-458. 2021
- Identification of prognostic factors in childhood T‐cell acute lymphoblastic leukemia: Results from DFCI ALL Consortium Protocols 05‐001 and 11‐001. Pediatric Blood and Cancer. 68:e28719. 2021
- Outcomes of haemoglobin Bart’s hydrops fetalis following intrauterine transfusion in Ontario, Canada. Archives of Disease in Childhood: Fetal and Neonatal Edition. 106:51-56. 2021
- Relationships of Bone Mineral Density to Whole Body Mass, Fat Mass and Fat-free Mass in Long-term Survivors of Acute Lymphoblastic Leukemia in Childhood. Journal of Pediatric Hematology/Oncology. 43:12-17. 2021
- Healthcare Utilization and Costs Associated with Different Treatment Protocols for Newly Diagnosed Childhood Acute Lymphoblastic Leukemia: A Population-Based Study. Blood. 136:46-47. 2020
- Outcomes of children with chronic myeloid leukemia: A population‐based cohort study. Pediatric Blood and Cancer. 67:e28491. 2020
- Utilising red cell antigen genotyping and serological phenotyping in sickle cell disease patients to risk‐stratify patients for alloimmunisation risk. Transfusion Medicine. 30:263-274. 2020
- Protective Effects of Dietary Intake of Antioxidants and Treatment-Related Toxicity in Childhood Leukemia: A Report From the DALLT Cohort. Journal of Clinical Oncology. 38:2151-2159. 2020
- Experience with ponatinib in paediatric patients with leukaemia. British Journal of Haematology. 189:363-368. 2020
- Hand Mirror Cells and Hypercalcemia: A Rare Presentation of Pediatric Acute Lymphoblastic Leukemia. Journal of Pediatric Hematology/Oncology. 42:e181-e184. 2020
- Fluctuations in dietary intake during treatment for childhood leukemia: A report from the DALLT cohort. Clinical Nutrition. 38:2866-2874. 2019
- Evaluating the endometabolic and bone health effects of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukaemia: a systematic review protocol. BMJ Open. 9:e030092-e030092. 2019
- Management of chronic myeloid leukemia in children and adolescents: Recommendations from the Children's Oncology Group CML Working Group. Pediatric Blood and Cancer. 66:e27827. 2019
- Outcome of Acute Myeloid Leukemia in Children Adolescents and Young Adults Treated with an Uniform Protocol in Casablanca, Morocco. Indian Journal of Hematology and Blood Transfusion. 35:255-259. 2019
- Feasibility and safety of delivering full‐dose anticoagulation therapy in children treated according to Dana‐Farber Cancer Institute acute lymphoblastic leukemia consortium therapy protocols. Pediatric Blood and Cancer. 66:e27483. 2019
- Impact of short stature on health-related quality of life in long-term survivors of acute lymphoblastic leukemia in childhood and adolescence. Journal of Patient-Reported Outcomes. 2:59. 2018
- Health Status and Health-related Quality of Life Measurement in Pediatric Cancer Clinical Trials: An Examination of the DFCI 00-01 Acute Lymphoblastic Leukemia Protocol. Journal of Pediatric Hematology/Oncology. 40:580-587. 2018
- Outcome of children and adolescents with Down syndrome treated on Dana‐Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium protocols 00–001 and 05‐001. Pediatric Blood and Cancer. 65:e27256. 2018
- Thromboembolism Incidence and Risk Factors in Children with Cancer: A Population-Based Cohort Study. Thrombosis and Haemostasis. 118:1646-1655. 2018
- Reply to comment on: Effectiveness of antibacterial prophylaxis during induction chemotherapy in children with acute lymphoblastic leukemia. Pediatric Blood and Cancer. 65:e27082. 2018
- Refining risk classification in childhood B acute lymphoblastic leukemia: results of DFCI ALL Consortium Protocol 05-001. Blood Advances. 2:1449-1458. 2018
- Effectiveness of antibacterial prophylaxis during induction chemotherapy in children with acute lymphoblastic leukemia. Pediatric Blood and Cancer. 65:e26952. 2018
- Impact of baseline clinical and laboratory features on the risk of thrombosis in children with acute lymphoblastic leukemia: A prospective evaluation. Pediatric Blood and Cancer. 65:e26938. 2018
- Iron overload in transfusion-dependent survivors of hemoglobin Bart’s hydrops fetalis. Haematologica. 103:e184-e187. 2018
- Body composition in long‐term survivors of acute lymphoblastic leukemia diagnosed in childhood and adolescence: A focus on sarcopenic obesity. Cancer. 124:1225-1231. 2018
- Prognostic impact of kinase-activating fusions and IKZF1 deletions in pediatric high-risk B-lineage acute lymphoblastic leukemia. Blood Advances. 2:529-533. 2018
- An investigation of toxicities and survival in Hispanic children and adolescents with ALL: Results from the Dana‐Farber Cancer Institute ALL Consortium protocol 05‐001. Pediatric Blood and Cancer. 65. 2018
- The identification of at‐risk patients and prevention of venous thromboembolism in pediatric cancer: guidance from the SSC of the ISTH. Journal of Thrombosis and Haemostasis. 16:175-180. 2018
- Evaluation for inherited and acquired prothrombotic defects predisposing to symptomatic thromboembolism in children with acute lymphoblastic leukemia: a protocol for a prospective, observational, cohort study. BMC Cancer. 17:313. 2017
- Health-related quality of life in long-term survivors of acute lymphoblastic leukemia in childhood and adolescence. Quality of Life Research. 26:1371-1377. 2017
- How Variable Is Our Delivery of Information? Approaches to Patient Education About Oral Chemotherapy in the Pediatric Oncology Clinic. Journal of Pediatric Health Care. 31:e1-e6. 2017
- Dietary intake and childhood leukemia: The Diet and Acute Lymphoblastic Leukemia Treatment (DALLT) cohort study. Nutrition. 32:1103-1109.e1. 2016
- Transfusion‐related alloimmunization in children: epidemiology and effects of chemotherapy. Vox Sanguinis. 111:299-307. 2016
- Fanconi Syndrome Secondary to Deferasirox in Diamond-Blackfan Anemia: Case Series and Recommendations for Early Diagnosis. Pediatric Blood and Cancer. 63:1480-1483. 2016
- Minimal Residual Disease and Childhood Leukemia: Standard of Care Recommendations From the Pediatric Oncology Group of Ontario MRD Working Group. Pediatric Blood and Cancer. 63:973-982. 2016
- Neurological PRESentations in Sickle Cell Patients Are Not Always Stroke: A Review of Posterior Reversible Encephalopathy Syndrome in Sickle Cell Disease. Pediatric Blood and Cancer. 63:983-989. 2016
- Intravenous pegylated asparaginase versus intramuscular native Escherichia coli l-asparaginase in newly diagnosed childhood acute lymphoblastic leukaemia (DFCI 05-001): a randomised, open-label phase 3 trial. The Lancet Oncology. 16:1677-1690. 2015
- The development of thromboembolism may increase the risk of osteonecrosis in children with acute lymphoblastic leukemia. Pediatric Blood and Cancer. 62:1851-1854. 2015
-
Development and validation of a generic scale for use in transition programmes to measure self‐management skills in adolescents with chronic health conditions: the
TRANSITION ‐Q . Child: Care, Health and Development. 41:547-558. 2015 - Pyomyositis Causing Temporary Quadriparesis During Induction Therapy for Acute Lymphoblastic Leukemia. Journal of Pediatric Hematology/Oncology. 37:223-226. 2015
- Body composition and bone health in long-term survivors of acute lymphoblastic leukaemia in childhood and adolescence: the protocol for a cross-sectional cohort study. BMJ Open. 5:e006191-e006191. 2015
- Impact of hemochromatosis gene mutations on cardiac status in doxorubicin‐treated survivors of childhood high‐risk leukemia. Cancer. 119:3555-3562. 2013
- Thrombosis in pediatric cancer: identifying the risk factors to improve care. Expert Review of Hematology. 6:599-609. 2013
- Postinduction Dexamethasone and Individualized Dosing of Escherichia Coli L-Asparaginase Each Improve Outcome of Children and Adolescents With Newly Diagnosed Acute Lymphoblastic Leukemia: Results From a Randomized Study—Dana-Farber Cancer Institute ALL Consortium Protocol 00-01. Journal of Clinical Oncology. 31:1202-1210. 2013
- Continuous Versus Bolus Infusion of Doxorubicin in Children With ALL: Long-term Cardiac Outcomes. Pediatrics. 130:1003-1011. 2012
- Do children with central venous line (CVL) dysfunction have increased risk of symptomatic thromboembolism compared to those without CVL-dysfunction, while on cancer therapy?. BMC Cancer. 12:314. 2012
- Corticosteroids, Behavior, and Quality of Life in Children Treated for Acute Lymphoblastic Leukemia; A Multicentered Trial. Journal of Pediatric Hematology/Oncology. 34:517-523. 2012
- Correction. Journal of Medical Genetics. 49:597-597. 2012
- Body mass index and thromboembolism in children with hematological malignancies. Pediatric Blood and Cancer. 59:320-322. 2012
- Predictors of bony morbidity in children with acute lymphoblastic leukemia. Pediatric Blood and Cancer. 59:77-82. 2012
- Central Venous Line Dysfunction is an Independent Predictor of Poor Survival in Children With Cancer. Journal of Pediatric Hematology/Oncology. 34:188-193. 2012
- Genetic analysis of inherited bone marrow failure syndromes from one prospective, comprehensive and population-based cohort and identification of novel mutations. Journal of Medical Genetics. 48:618-628. 2011
- The low incidence of secondary acute myelogenous leukaemia in children and adolescents treated with dexrazoxane for acute lymphoblastic leukaemia: A report from the Dana-Farber Cancer Institute ALL Consortium. European Journal of Cancer. 47:1373-1379. 2011
- Comparative analysis of Shwachman-Diamond syndrome to other inherited bone marrow failure syndromes and genotype-phenotype correlation. Clinical Genetics. 79:448-458. 2011
- Assessment of dexrazoxane as a cardioprotectant in doxorubicin-treated children with high-risk acute lymphoblastic leukaemia: long-term follow-up of a prospective, randomised, multicentre trial. The Lancet Oncology. 11:950-961. 2010
- Assessment of dexrazoxane as a cardioprotectant in doxorubicin-treated children with high-risk acute lymphoblastic leukaemia: long-term follow-up of a prospective, randomised, multicentre trial.. The Lancet Oncology. 11:950-961. 2010
- Von Willebrand factor and thrombin activation in children with newly diagnosed acute lymphoblastic leukemia: An impact of peripheral blasts. Pediatric Blood and Cancer. 54:963-969. 2010
- Tonsillectomy and Adenoidectomy For Obstructive Sleep Apnea in Sickle Cell Anemia. Indian Journal of Pediatrics. 77:669-672. 2010
- Intravenous PEG-asparaginase during remission induction in children and adolescents with newly diagnosed acute lymphoblastic leukemia. Blood. 115:1351-1353. 2010
- Erwinia asparaginase after allergy to E. coli asparaginase in children with acute lymphoblastic leukemia. Pediatric Blood and Cancer. 54:199-205. 2010
- Childhood Atypical Teratoid Rhabdoid Tumor of the Central Nervous System. Journal of Pediatric Hematology/Oncology. 31:651-663. 2009
- Epidemiology and clinical risk factors predisposing to thromboembolism in children with cancer. Pediatric Blood and Cancer. 51:792-797. 2008
- Clinical and Genetic Analysis of Unclassifiable Inherited Bone Marrow Failure Syndromes. Pediatrics. 122:e139-e148. 2008
- Absence of Secondary Malignant Neoplasms in Children With High-Risk Acute Lymphoblastic Leukemia Treated With Dexrazoxane. Journal of Clinical Oncology. 26:1106-1111. 2008
- Thromboembolism in children with lymphoma. Thrombosis Research. 122:459-465. 2008
- Thromboembolism in children with sarcoma. Pediatric Blood and Cancer. 49:171-176. 2007
- Hemorrhagic Complications in Pediatric Hematologic Malignancies. Seminars in Thrombosis and Hemostasis. 33:408-415. 2007
- Thromboembolic Complications in Pediatric Hematologic Malignancies. Seminars in Thrombosis and Hemostasis. 33:416-426. 2007
- Thromboembolic complications in children with cancer. Thrombosis Research. 118:137-152. 2006
- Thromboembolism in children with acute lymphoblastic leukaemia treated on Dana‐Farber Cancer Institute protocols: effect of age and risk stratification of disease. British Journal of Haematology. 129:803-810. 2005
- Methemoglobinemia in children with acute lymphoblastic leukemia (ALL) receiving dapsone forpneumocystis carinii pneumonia (PCP) prophylaxis: A correlation with cytochrome b5 reductase (Cb5R) enzyme levels. Pediatric Blood and Cancer. 44:55-62. 2005
- Acute Perforative Appendicitis During Preoperative Chemotherapy for Wilms Tumor. Pediatric Hematology and Oncology. 20:147-150. 2003
- Thrombosis in children with acute lymphoblastic leukemia. Thrombosis Research. 111:321-327. 2003
- Thrombosis in children with acute lymphoblastic leukemia. Thrombosis Research. 111:199-212. 2003
- Thrombosis in children with acute lymphoblastic leukemia. Thrombosis Research. 111:125-131. 2003
- Skeletal Manifestations of Pediatric Acute Megakaryoblastic Leukemia. Journal of Pediatric Hematology/Oncology. 24:561-565. 2002
- Phase I Study of Combination Topotecan and Carboplatin in Pediatric Solid Tumors. Journal of Clinical Oncology. 20:88-95. 2002
- Phase I Study of Combination Topotecan and Carboplatin in Pediatric Solid Tumors. Journal of Clinical Oncology. 20:88-95. 2002
- Biology and outcome of childhood acute megakaryoblastic leukemia: a single institution's experience. Blood. 97:3727-3732. 2001
- Use of Reverse Transcriptase Polymerase Chain Reaction for Diagnosis and Staging of Alveolar Rhabdomyosarcoma, Ewing Sarcoma Family of Tumors, and Desmoplastic Small Round Cell Tumor. Journal of Pediatric Hematology/Oncology. 23:99-104. 2001
- Splenic rupture in children with hematologic malignancies. Cancer. 88:480-490. 2000
- Poland's syndrome and Wilms tumor: An unusual association. Pediatric Blood and Cancer. 30:67-68. 1998
- Childhood cancers in Zambia before and after the HIV epidemic.. Archives of Disease in Childhood. 73:100-105. 1995
- Chromosome investigations & clinical outcome in patients with myelodysplastic syndromes.. Indian Journal of Medical Research. 101:163-169. 1995
- Influence of HIV Epidemic on the Incidence of Kaposi??s Sarcoma in Zambian Children. Journal of Acquired Immune Deficiency Syndromes (1999). 8:96???100-96???100. 1995
- The Effect of Sickle Cell Anaemia on Adolescents and Their Growth and Development-Lessons from the Sickle Cell Anaemia Clinic. Journal of Tropical Pediatrics. 40:246-252. 1994
- Clinical analysis of mortality in hospitalized Zambian children with sickle cell anaemia.. East African Medical Journal. 71:388-391. 1994
- Aniridia--Wilms' tumour association--a case with 11p 13-14.1 deletion and ventricular septal defect.. Indian Journal of Cancer. 29:117-121. 1992
- How safe is BCG vaccination in children born to HIV-positive mothers?. The Lancet. 340:434-435. 1992
- Fanconi's anemia: a clinico-hematological and cytogenetic study.. Indian Pediatrics. 28:1003-1011. 1991
- Acute leukemia in Down's syndrome.. Indian Pediatrics. 27:73-75. 1990
-
preprints